Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 1 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 22:09 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantShares of Common Stock held in my name | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006657 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,371.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:52 UTC |
Shelly Timothy J.Sr.VP Operations
|
GrantCommon Stock | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006648 · rdgdoc.xml · nonDerivative · entry 1 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,294 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:29 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantCommon Stock | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006618 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,237 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:27 UTC |
KIDD BRIAN FSVP, CFO
|
GrantCommon Stock | 1,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006614 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,224 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006611 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,400 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:19 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantCommon Stock | 1,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006607 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,459.0547 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:24 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005667 · rdgdoc.xml · derivative · entry 5 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-23 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:22 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005659 · rdgdoc.xml · derivative · entry 5 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:18 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantOption to Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005654 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-02-28 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:15 UTC |
KIDD BRIAN FSVP, CFO
|
GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005651 · rdgdoc.xml · derivative · entry 5 KIDD BRIAN F · CIK 0001693922 · SVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:14 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005645 · rdgdoc.xml · derivative · entry 5 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:10 UTC |
Shelly Timothy J.Sr.VP Operations
|
GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005640 · rdgdoc.xml · derivative · entry 5 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC |
ABERNATHY JAMES PAULDirector
|
Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC |
ABERNATHY JAMES PAULDirector
|
Tax withholdingShares of Common Stock | 3,732 | $139.01 | $518,785.32 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,162 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:01 UTC |
ABERNATHY JAMES PAULDirector
|
Exercise / conversionShares of Common Stock | 7,500 | $69.82 | $523,650.00 |
DisclosureSEC source: 0001437749-26-001443 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:47 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Tax withholdingCommon Stock | 403 | $137.09 | $55,247.27 |
DisclosureSEC source: 0001437749-26-000380 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,117.0547 F1 · shares: On 1/1/2026, 33 1/3 (or 1070 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 403 shares to pay tax obligations. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:43 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Tax withholdingShares of Common Stock held in my name | 319 | $137.09 | $43,731.71 |
DisclosureSEC source: 0001437749-26-000369 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,289.5455 F1 · shares: On 1/1/2026, 33 1/3 (or 846 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 319 shares to pay tax obligations. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:41 UTC |
KIDD BRIAN FSVP, CFO
|
Tax withholdingCommon Stock | 447 | $137.09 | $61,279.23 |
DisclosureSEC source: 0001437749-26-000365 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,693 F1 · shares: On 1/1/2026, 33 1/3 (or 1185 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 447 shares to pay tax obligations. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:54 UTC |
Ussery Robert MichaelPresident & COO
|
Tax withholdingCommon Stock | 2,063 | $137.09 | $282,816.67 |
DisclosureSEC source: 0001437749-26-000387 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,460 F1 · shares: On 1/1/2026, 4835 of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 2063 shares to pay tax obligations. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:03 UTC |
Flatt Stephen FowlerDirector · CEO
|
GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038931 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,171 Read SEC document |
| December 23, 2025 Filed Dec 29, 2025 21:02 UTC |
KIDD BRIAN FSVP, CFO
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038826 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,140 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 6 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,523 F1 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 5 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,568 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 4 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,608 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 3 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,348 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 2 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,443 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:31 UTC |
Ussery Robert MichaelPresident & COO
|
GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038283 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,483 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:32 UTC |
Shelly Timothy J.Sr.VP Operations
|
SaleCommon Stock | 2,454 | $139.42 | $342,136.68 |
DisclosureSEC source: 0001437749-25-038286 · rdgdoc.xml · nonDerivative · entry 1 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 21:20 UTC |
Flatt Stephen FowlerDirector · CEO
|
GiftCommon Stock | 145 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037850 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,621 F1 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 21:20 UTC |
Flatt Stephen FowlerDirector · CEO
|
GiftCommon Stock | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037850 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,766 Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:48 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 3,734 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-25-036805 · rdgdoc.xml · derivative · entry 3 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,734 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:48 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Tax withholdingCommon Stock | 2,385 | $137.29 | $327,436.65 |
DisclosureSEC source: 0001437749-25-036805 · rdgdoc.xml · nonDerivative · entry 2 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,520.0547 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:48 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Exercise / conversionCommon Stock | 3,734 | $63.96 | $238,826.64 |
DisclosureSEC source: 0001437749-25-036805 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,905.0547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 21:18 UTC |
Flatt Stephen FowlerDirector · CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 1,853 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,147 Underlying: Common Stock · 8,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 21:18 UTC |
Flatt Stephen FowlerDirector · CEO
|
Exercise / conversionCommon Stock | 1,853 | $53.94 | $99,950.82 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:02 UTC |
HASSAN EMIL EDirector
|
SaleShares of Common Stock | 7,500 | $138.52 | $1,038,873.00 |
DisclosureSEC source: 0001437749-25-036441 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,595 Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · derivative · entry 4 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Tax withholdingShares of Common Stock held in my name | 3,140 | $137.95 | $433,163.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,608.5455 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 20:41 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Exercise / conversionShares of Common Stock held in my name | 4,000 | $94.10 | $376,400.00 |
DisclosureSEC source: 0001437749-25-036492 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,748.5455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:18 UTC |
Flatt Stephen FowlerDirector · CEO
|
SaleCommon Stock | 1,000 | $130.33 | $130,330.00 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,130 Read SEC document |
| November 12, 2025 Filed Nov 12, 2025 23:42 UTC |
HASSAN EMIL EDirector
|
SaleShares of Common Stock | 5,500 | $133.00 | $731,500.00 |
DisclosureSEC source: 0001437749-25-034547 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,095 F1 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · derivative · entry 6 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 13,500 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · derivative · entry 5 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 9,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Tax withholdingCommon Stock | 3,720 | $132.20 | $491,784.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · nonDerivative · entry 4 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,523 F3 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F4 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Exercise / conversionCommon Stock | 4,500 | $94.10 | $423,450.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · nonDerivative · entry 3 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Tax withholdingCommon Stock | 1,705 | $132.20 | $225,401.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · nonDerivative · entry 2 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,743 F3 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:51 UTC |
Ussery Robert MichaelPresident & COO
|
Exercise / conversionCommon Stock | 4,500 | $53.94 | $242,730.00 |
DisclosureSEC source: 0001437749-25-034919 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:25 UTC |
Shelly Timothy J.Sr.VP Operations
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 4,800 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-034907 · rdgdoc.xml · derivative · entry 6 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 7,200 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:25 UTC |
Shelly Timothy J.Sr.VP Operations
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,400 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-25-034907 · rdgdoc.xml · derivative · entry 5 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,400 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:25 UTC |
Shelly Timothy J.Sr.VP Operations
|
Tax withholdingCommon Stock | 3,091 | $132.20 | $408,630.20 |
DisclosureSEC source: 0001437749-25-034907 · rdgdoc.xml · nonDerivative · entry 4 Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,454 F3 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.